Purchase Short-Term Access

Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality

Donna Fedorkow, MD

Annals of Internal Medicine 2011;155:JC3-8. doi:10.7326/0003-4819-155-6-201109200-02008

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)